Site-specific DNA-antibody conjugates for specific and sensitive immuno-PCR

Antibody conjugates are widely used as diagnostics and imaging reagents. However, many such conjugates suffer losses in sensitivity and specificity due to nonspecific labeling techniques. We have developed methodology to site-specifically conjugate oligonucleotides to antibodies containing a genetically encoded unnatural amino acid with orthogonal chemical reactivity. These oligobody molecules were used in immuno-PCR assays to detect Her2+ cells with greater sensitivity and specificity than nonspecifically coupled fragments, and can detect extremely rare Her2+ cells in a complex cellular environment. Such designed antibody-oligonucleotide conjugates should provide sensitive and specific reagents for diagnostics, as well as enable other unique applications based on oligobody building blocks.

[1]  F. Lasne,et al.  Double-blotting: a solution to the problem of non-specific binding of secondary antibodies in immunoblotting procedures. , 2001, Journal of immunological methods.

[2]  Carolina Wählby,et al.  In Situ Detection of Phosphorylated Platelet-derived Growth Factor Receptor β Using a Generalized Proximity Ligation Method* , 2007, Molecular & Cellular Proteomics.

[3]  Hanlee P. Ji,et al.  Multiplexed protein detection by proximity ligation for cancer biomarker validation , 2007, Nature Methods.

[4]  P. Schultz,et al.  Site-specific coupling and sterically controlled formation of multimeric antibody fab fragments with unnatural amino acids. , 2011, Journal of molecular biology.

[5]  Mikael Kubista,et al.  Development and evaluation of three real-time immuno-PCR assemblages for quantification of PSA. , 2005, Journal of immunological methods.

[6]  A. Laenkholm,et al.  ER, HER2, and TOP2A expression in primary tumor, synchronous axillary nodes, and asynchronous metastases in breast cancer , 2012, Breast Cancer Research and Treatment.

[7]  G. Hortobagyi,et al.  Prognostic value of HER2-positive circulating tumor cells in patients with metastatic breast cancer , 2012, International Journal of Clinical Oncology.

[8]  K. Isselbacher,et al.  Isolation of circulating tumor cells using a microvortex-generating herringbone-chip , 2010, Proceedings of the National Academy of Sciences.

[9]  J. Montero,et al.  Activation of ErbB2 by overexpression or by transmembrane neuregulin results in differential signaling and sensitivity to herceptin. , 2005, Cancer research.

[10]  John M Lambert,et al.  Structural characterization of the maytansinoid–monoclonal antibody immunoconjugate, huN901–DM1, by mass spectrometry , 2005, Protein science : a publication of the Protein Society.

[11]  M. Husain,et al.  Fc site-specific labeling of immunoglobulins with calf intestinal alkaline phosphatase. , 1994, Bioconjugate chemistry.

[12]  S. Kingsmore,et al.  Immunoassays with rolling circle DNA amplification: a versatile platform for ultrasensitive antigen detection. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Peter Kuhn,et al.  A rare-cell detector for cancer. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Harry M. T. Choi,et al.  Programming biomolecular self-assembly pathways , 2008, Nature.

[15]  P. Lambin,et al.  Measurement of anti‐D intrinsic affinity with unlabeled antibodies , 2004, Transfusion.

[16]  D. Rimm,et al.  Antibody validation by quantitative analysis of protein expression using expression of Met in breast cancer as a model , 2007, Laboratory Investigation.

[17]  Gabriel A Kwong,et al.  DNA-encoded antibody libraries: a unified platform for multiplexed cell sorting and detection of genes and proteins. , 2007, Journal of the American Chemical Society.

[18]  Daniel Irimia,et al.  Ultrasensitive detection of low-abundance surface-marker protein using isothermal rolling circle amplification in a microfluidic nanoliter platform. , 2011, Small.

[19]  P. Schultz,et al.  Addition of the keto functional group to the genetic code of Escherichia coli , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Tsukiji,et al.  Site-specific conjugation of oligonucleotides to the C-terminus of recombinant protein by expressed protein ligation. , 2004, Bioorganic & medicinal chemistry letters.

[21]  C. Mirkin,et al.  Nanoparticle-Based Bio-Bar Codes for the Ultrasensitive Detection of Proteins , 2003, Science.

[22]  Alison Stopeck,et al.  Circulating tumor cells, disease progression, and survival in metastatic breast cancer. , 2004, The New England journal of medicine.

[23]  N. Sneige,et al.  Stability of HER2-positive status in breast carcinoma: a comparison between primary and paired metastatic tumors with regard to the possible impact of intervening trastuzumab treatment. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[24]  P. Dawson,et al.  Nucleophilic catalysis of oxime ligation. , 2006, Angewandte Chemie.

[25]  Peter Kuhn,et al.  Cytomorphology of Circulating Colorectal Tumor Cells:A Small Case Series , 2010, Journal of oncology.

[26]  U. Landegren,et al.  Direct observation of individual endogenous protein complexes in situ by proximity ligation , 2006, Nature Methods.

[27]  J. Nieva,et al.  Case study of the morphologic variation of circulating tumor cells. , 2007, Human pathology.

[28]  Christof M Niemeyer,et al.  A real-time immuno-PCR assay for routine ultrasensitive quantification of proteins. , 2003, Biochemical and biophysical research communications.

[29]  M. Gilcrease.  Prognostic and predictive value of HER2 extracellular domain in metastatic breast cancer treated with lapatinib and paclitaxel in a randomized phase III study , 2010 .

[30]  H. Klocker,et al.  Nanoparticle-based bio-barcode assay redefines “undetectable” PSA and biochemical recurrence after radical prostatectomy , 2009, Proceedings of the National Academy of Sciences.

[31]  P. Schultz,et al.  Selective formation of covalent protein heterodimers with an unnatural amino acid. , 2011, Chemistry & biology.

[32]  K. Syrigos,et al.  Analytic Variability in Immunohistochemistry Biomarker Studies , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[33]  M. Uhlén,et al.  Selective enrichment of monospecific polyclonal antibodies for antibody-based proteomics efforts. , 2004, Journal of chromatography. A.

[34]  Christof M Niemeyer,et al.  Immuno-PCR: high sensitivity detection of proteins by nucleic acid amplification. , 2005, Trends in biotechnology.

[35]  Valsamo Anagnostou,et al.  Antibody validation. , 2010, BioTechniques.

[36]  C. Niemeyer,et al.  Detecting antigens by quantitative immuno-PCR , 2007, Nature Protocols.

[37]  Hongtao Zhang,et al.  A sensitive and high-throughput assay to detect low-abundance proteins in serum , 2006, Nature Medicine.

[38]  Anna M Wu,et al.  Arming antibodies: prospects and challenges for immunoconjugates , 2005, Nature Biotechnology.

[39]  A. Gordon,et al.  Using protein-DNA chimeras to detect and count small numbers of molecules , 2005, Nature Methods.

[40]  C R Cantor,et al.  Immuno-PCR: very sensitive antigen detection by means of specific antibody-DNA conjugates. , 1992, Science.

[41]  Jonas Jarvius,et al.  Cytokine detection by antibody-based proximity ligation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.